We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-3.06%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$77.7B
AUM Growth
-$3.9B
(-4.8%)
Cap. Flow
+$505M
Cap. Flow
% of AUM
0.65%
Top 10 Holdings %
Top 10 Hldgs %
24.09%
Holding
3,066
New
55
Increased
1,481
Reduced
1,461
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$83.5M |
| 2 |
S&P Global
SPGI
|
+$73.5M |
| 3 |
Tesla
TSLA
|
+$55.8M |
| 4 |
Microsoft
MSFT
|
+$45.9M |
| 5 |
Amazon
AMZN
|
+$27.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$88.8M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$74.7M |
| 3 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$31.7M |
| 4 |
Abbott
ABT
|
+$25.5M |
| 5 |
Exelon
EXC
|
+$23.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.74% |
| 2 | Financials | 13.53% |
| 3 | Healthcare | 13.01% |
| 4 | Consumer Discretionary | 11.66% |
| 5 | Industrials | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDUS
2476
DELISTED
Radius Health, Inc.
RDUS
| $445K | ﹤0.01% |
50,359
-2,385
| -5% | -$18.1K |
|
2477
Caribou Biosciences
CRBU
$164M
| $444K | ﹤0.01% |
48,358
+28,633
| +145% | +$302K |
|
|
SEI
2478
Solaris Energy Infrastructure
SEI
$3.82B
| $443K | ﹤0.01% |
39,267
-868
| -2% | -$7.86K |
|
2479
Lands' End
LE
$403M
| $440K | ﹤0.01% |
25,977
-1,096
| -4% | -$19.6K |
|
2480
Ocular Therapeutix
OCUL
$2.02B
| $439K | ﹤0.01% |
88,667
+1,549
| +2% | +$8.59K |
|
2481
MetroCity Bankshares
MCBS
$1.03B
| $437K | ﹤0.01% |
18,605
-937
| -5% | -$23.6K |
|
|
BLUE
2482
DELISTED
bluebird bio
BLUE
| $436K | ﹤0.01% |
4,492
-382
| -8% | -$50.4K |
|
2483
Omeros
OMER
$959M
| $434K | ﹤0.01% |
72,153
+958
| +1% | +$5.98K |
|
2484
Lindblad Expeditions
LIND
$2.22B
| $432K | ﹤0.01% |
28,632
+1,067
| +4% | +$17.2K |
|
|
EWCZ
2485
DELISTED
European Wax Center
EWCZ
| $431K | ﹤0.01% |
14,584
+4,885
| +50% | +$127K |
|
2486
SmartFinancial
SMBK
$888M
| $431K | ﹤0.01% |
16,868
-1,628
| -9% | -$43.1K |
|
|
NOTV
2487
DELISTED
Inotiv
NOTV
| $430K | ﹤0.01% |
16,407
+4,216
| +35% | +$118K |
|
2488
Aviat Networks
AVNW
$273M
| $429K | ﹤0.01% |
13,944
+1,864
| +15% | +$54.4K |
|
|
YMAB
2489
DELISTED
Y-mAbs Therapeutics
YMAB
| $429K | ﹤0.01% |
36,092
-325
| -0.9% | -$3.34K |
|
2490
iShares S&P Mid-Cap 400 Value ETF
IJJ
$9.03B
| $428K | ﹤0.01% |
+3,900
| New | +$421K |
|
|
DSKE
2491
DELISTED
Daseke, Inc. Common Stock
DSKE
| $427K | ﹤0.01% |
42,449
-2,083
| -5% | -$22.6K |
|
2492
RBB Bancorp
RBB
$455M
| $426K | ﹤0.01% |
18,149
-1,558
| -8% | -$40K |
|
2493
GCM Grosvenor
GCMG
$820M
| $424K | ﹤0.01% |
43,697
+9,568
| +28% | +$94.6K |
|
2494
Rush Enterprises Class B
RUSHB
$6.14B
| $424K | ﹤0.01% |
13,161
-1,211
| -8% | -$40.2K |
|
2495
Lifecore Biomedical
LFCR
$190M
| $422K | ﹤0.01% |
36,410
-3,120
| -8% | -$34.7K |
|
2496
Praxis Precision Medicines
PRAX
$10.1B
| $422K | ﹤0.01% |
2,758
+231
| +9% | +$47.5K |
|
2497
Miller Industries
MLR
$619M
| $421K | ﹤0.01% |
14,956
-1,252
| -8% | -$38.6K |
|
2498
Primis Financial Corp
FRST
$404M
| $420K | ﹤0.01% |
30,022
-2,901
| -9% | -$42.9K |
|
|
KBAL
2499
DELISTED
Kimball International
KBAL
| $419K | ﹤0.01% |
49,593
-4,441
| -8% | -$42.2K |
|
2500
Omega Flex
OFLX
$312M
| $418K | ﹤0.01% |
3,217
-16
| -0.5% | -$2.23K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2022 Portfolio in Review
As of Q1 2022, RhumbLine Advisers held 3,066 positions worth $77.7B, down 4.8% from $81.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Trading was light in Q1 2022: portfolio turnover was 3.5%. RhumbLine Advisers opened 55 new positions and exited 51, leaving the 3,066-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2022 buy was Constellation Energy: 528,261 shares worth $29.7M.
- RhumbLine Advisers added most to Advanced Micro Devices in Q1 2022, an estimated $83.5M increase.
- RhumbLine Advisers's biggest Q1 2022 reduction was Abbott, cutting an estimated $25.5M.
- RhumbLine Advisers fully exited Xilinx Inc in Q1 2022, selling an estimated $88.8M.
- RhumbLine Advisers's ten largest holdings make up 24% of its $77.7B portfolio in Q1 2022.
- RhumbLine Advisers opened 55 new positions and closed 51 in Q1 2022.
- RhumbLine Advisers's portfolio value fell 4.8% quarter-over-quarter to $77.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2022, filed 12 May 2022.